Latest News

Members of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM) at Yale School of Medicine were honored during the American Thoracic Society (ATS) 2022 International Conference in San Francisco.

Three faculty from Yale’s Department of Internal Medicine were recently nominated for election to the American Society for Clinical Investigation (ASCI). A total of 95 new members have been elected for 2022, and will officially inducted at the ASCI Dinner and New Member Induction Ceremony in April.

Yale-PCCSM's Dela Cruz and Ferrante are recognized as physician-scientists.

A new study by Yale researchers provides a single-cell resolution profile of the inflammatory severe COVID-19 disease, and the loss of coordination between the innate and adaptive immune response. This loss of coordination has the potential to amplify a person’s immune response to COVID-19, delaying viral clearance.

There is not one set path to becoming a physician-scientist. Some physician-scientists attend medical school and obtain their PhD as part of an MD-PhD program. Some obtain their PhD prior to medical school or later during clinical fellowship. Others go to medical school, while simultaneously conducting research outside of a formal program. But there is one common thread—the love for both clinical care and scientific research.

For the past year, experts across various disciplines have studied and carefully considered each new piece of evidence about treatment strategies for COVID-19 and translated it into standardized guidelines for Yale School of Medicine and Yale New Haven Health System clinicians

Known as LAM-002A (apilimod), the drug has a proven safety record. Preliminary research has shown it can block cellular entry and trafficking of the SARS-CoV-2 virus, the cause of COVID-19.

(Reuters) - Devon Brumfield could hear her father gasping for breath on the phone.

Have a Condition That Can Affect Breathing? What You Need to Know About COVID-19.